Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease.
第一作者:
Xuan,Li
第一单位:
UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
作者:
医学主题词
成年人(Adult);人体质量指数(Body Mass Index);支气管扩张药(Bronchodilator Agents);胆碱能拮抗剂(Cholinergic Antagonists);女(雌)性(Female);用力呼气量(Forced Expiratory Volume);基因表达(Gene Expression);人类(Humans);异丙托铵(Ipratropium);男(雄)性(Male);中年人(Middle Aged);肺疾病, 慢性阻塞性(Pulmonary Disease, Chronic Obstructive);受体, 毒蕈碱M2(Receptor, Muscarinic M2);受体, 毒蕈碱M3(Receptor, Muscarinic M3);性征(Sex Characteristics);治疗结果(Treatment Outcome)
DOI
10.1016/j.ebiom.2017.04.020
PMID
28461224
发布时间
2022-04-08
- 浏览53
EBioMedicine
2017年19卷
139-145页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



